Xanthine Derivatives Reveal an Allosteric Binding Site in Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2)

por Lee, Lung-Chun, Peng, Yi-Hui, Chang, Hsin-Huei, Hsu, Tsu, Lu, Cheng-Tai, Huang, Chih-Hsiang, Hsueh, Ching-Cheng, Kung, Fang-Chun, Kuo, Ching-Chuan, Jiaang, Weir-Torn, Wu, Su-Ying
Publicado 2021

BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor

por Tsai, Hui‐Jen, Jiaang, Weir‐Torn, Shih, Neng‐Yao, Fletcher, Jonathan A., Lin, Ming‐Jon, Yang, Ming‐Yu, Chen, Chiung‐Tong, Hsu, Tsu‐An John, Wu, Chun‐Chieh, Lin, Hui‐You, Chen, Li‐Tzong
Publicado 2018

Identification of Novel Anti-Liver Cancer Small Molecules with Better Therapeutic Index Than Sorafenib via Zebrafish Drug Screening Platform

por Lin, Han-Syuan, Huang, Yi-Luen, Wang, Yi-Rui Stefanie, Hsiao, Eugene, Hsu, Tsu-An, Shiao, Hui-Yi, Jiaang, Weir-Torn, Sampurna, Bonifasius Putera, Lin, Kuan-Hao, Wu, Ming-Shun, Lai, Gi-Ming, Yuh, Chiou-Hwa
Publicado 2019

Evaluation of the Antitumor Effects of BPR1J-340, a Potent and Selective FLT3 Inhibitor, Alone or in Combination with an HDAC Inhibitor, Vorinostat, in AML Cancer

por Lin, Wen-Hsing, Yeh, Teng-Kuang, Jiaang, Weir-Torn, Yen, Kuei-Jung, Chen, Chun-Hwa, Huang, Chin-Ting, Yen, Shih-Chieh, Hsieh, Shu-Yi, Chou, Ling-Hui, Chen, Ching-Ping, Chiu, Chun-Hsien, Kao, Li-Chun, Chao, Yu-Sheng, Chen, Chiung-Tong, Hsu, John T.-A.
Publicado 2014